Infectious Disease Update - What’s New in ID?

McMaster University Department of Medicine

A. Kapoor

Risk Factors for C. difficile Infection

Peggy Lillis Foundation

V. Young

Proton Pump Inhibitors: Debunking Media Myths

Houston Methodist

C. Kim

A Clinician's Guide to the Basics of the Microbiota and FMT for Gast…

Paul Feuerstadt

Vedanta's Clinical Trials to Prevent Recurrent C. diff Infections: T…

Peggy Lillis Foundation

S. Shiff

Hot Topic: C. diff and IBD

Icahn School of Medicine at Mount Sinai

A. Grinspan

Moderation of the Microbiome and C. difficile Infection: Have We Fin…

ACG 2023 Conference Coverage

P. Feuerstadt

Updates in Fecal Microbiota Transplantation

UCSF School of Medicine

M. Brondfield

Diagnosis and Treatment of Clostridioides difficile and Recurrent In…

ACG 2024 Conference Coverage

N. Stollman

When and What to Test for Diarrhea: Focus on Stool Testing

ACG 2024 Conference Coverage

M. Camilleri

Management of C. difficile Infections: GI Society Guidelines

Peggy Lillis Foundation

C. Kelly

Diagnosis of C. difficile Infection

Peggy Lillis Foundation

E. Dubberke

Harnessing the Microbiome to Treat Gut Disease: Myth or Reality?

Keck School of Medicine of USC

B. Zhang

Pediatric C. difficile Infection

Peggy Lillis Foundation

M. Nicholson

C. Difficile Colitis: Management in 2024

Stanford Medicine

K. Keyashian

Novel Small Molecule Treatment for C. difficile Infection, REC-3964

Peggy Lillis Foundation

A. Skinner

AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies …

DDW 2024 Conference Coverage

C. Kelly

Two-Way Patient Management: ID and Primary Care

Baystate Health

C. Magauran

Panel Discussion: The IDSA Vs. ACG Guidelines for Antimicrobial Mana…

Peggy Lillis Foundation

P. Feuerstadt

Reduced Vancomycin Susceptibility in Clostridioides difficile is Ass…

Taryn Eubank

C. Dureja